RxDoctor Payments DataLook up a doctor →

Christopher Carey, MD

Neurology · Ocean Springs, MSNPI 1932604022

Payments from drug & device makers

$16,105in general payments, 2019–2025

Across 846 payments — averaging $19.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • UCB, Inc.$1K
  • AstraZeneca$1K
  • Acadia Pharmaceuticals Inc$1K
  • SK Life Science, Inc.$825
  • Eisai Inc.$783
  • plus $9K from 48 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)139$2,083
UCB, Inc.54$1,159
AstraZeneca(2 entities)46$1,142
Acadia Pharmaceuticals Inc54$1,024
SK Life Science, Inc.39$825
Eisai Inc.39$783
Pfizer53$743
Novartis37$705
Amgen(2 entities)28$667
EMD Serono, Inc.27$599
Lilly USA, LLC30$512
Biogen30$506
Neurocrine Biosciences, Inc.22$487
Teva Pharmaceuticals USA, Inc.20$457
Lundbeck LLC23$452
Genentech USA, Inc.20$440
Argenx US, Inc.19$377
Bristol Myers Squibb19$372
Merz Pharmaceuticals, LLC13$270
TG Therapeutics, Inc.15$236
Johnson & Johnson(2 entities)7$210
Acorda Therapeutics, Inc12$209
Jazz Pharmaceuticals Inc.9$179
ANI Pharmaceuticals, Inc.9$175
Otsuka America Pharmaceutical, Inc.9$157
Neurelis, Inc.8$142
Takeda Pharmaceuticals U.S.A., Inc.6$124
Sanofi4$122
Mallinckrodt Hospital Products Inc.4$72
Sumitomo Pharma America, Inc.9$67
Ipsen Biopharmaceuticals, Inc3$65
CSL Behring3$64
Microtransponder, Inc.1$59
Adamas Pharmaceuticals, Inc.3$56
Amylyx Pharmaceuticals, Inc.2$56
Amneal Pharmaceuticals LLC3$53
Tanabe Pharma America, Inc.3$47
Vanda Pharmaceuticals Inc.3$45
Biohaven Pharmaceutical Holding Company Ltd.2$44
Azurity Pharmaceuticals, Inc.3$39
Revance Therapeutics, Inc.2$37
Scilex Pharmaceuticals Inc.2$36
Banner Life Sciences, LLC1$21
Avion Pharmaceuticals1$20
Cycle Pharmaceuticals Inc1$20
Akcea Therapeutics, Inc.1$19
Boston Scientific1$18
MDD US Operations, LLC1$17
Almatica Pharma LLC1$17
Chiesi USA, Inc.1$16
Boehringer Ingelheim1$15
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$15
Supernus Pharmaceuticals, Inc.1$15
Kyowa Kirin, Inc.1$14

How this compares

$16,105 in reported general payments places this provider in the 70th percentile of 111 neurology providers in Mississippi.

See all neurology providers in Mississippi →

Medicare billing

Part B allowed, 2024
$81,393
Medicare patients
340
Services billed
699

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Ocean Springs

See the full list for Mississippi →

Where these figures come from

Is this you, or does something look wrong? →